Skip to main navigation Skip to search Skip to main content

Didox (a novel ribonucleotide reductase inhibitor) overcomes bcl-2 mediated radiation resistance in prostate cancer cell line PC-3

  • Mohammed S. Inayat
  • , Damodaran Chendil
  • , Mohammed Mohiuddin
  • , Howard L. Elford
  • , Vincent S. Gallicchio
  • , Mansoor M. Ahmed

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Didox (a novel ribonucleotide reductase inhibitor) overcomes bcl-2 mediated radiation resistance in prostate cancer cell line PC-3'. Together they form a unique fingerprint.
Sort by

Keyphrases

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science